You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for technetium tc-99m albumin aggregated kit

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02773238 ↗ FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging Recruiting National Cancer Institute (NCI) Phase 2 2016-05-01 This phase II trial studies how well positron emission tomography (PET)/computed tomography (CT) and single positron emission computed tomography (SPECT)/CT imaging works in improving radiation therapy treatment in patients with stage IIB-IIIB non-small cell lung cancer. PET/CT imaging mid-way through treatment may be able to accurately show how well radiation therapy and chemotherapy are working. SPECT/CT imaging may be able to tell which parts of the lung tissue are healthier than others. Based on the result of the imaging, treatment adjustments may be made to the radiation therapy to improve survival and decrease toxicity.
NCT02773238 ↗ FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging Recruiting University of Washington Phase 2 2016-05-01 This phase II trial studies how well positron emission tomography (PET)/computed tomography (CT) and single positron emission computed tomography (SPECT)/CT imaging works in improving radiation therapy treatment in patients with stage IIB-IIIB non-small cell lung cancer. PET/CT imaging mid-way through treatment may be able to accurately show how well radiation therapy and chemotherapy are working. SPECT/CT imaging may be able to tell which parts of the lung tissue are healthier than others. Based on the result of the imaging, treatment adjustments may be made to the radiation therapy to improve survival and decrease toxicity.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for technetium tc-99m albumin aggregated kit

Condition Name

Condition Name for technetium tc-99m albumin aggregated kit
Intervention Trials
Stage IIB Non-Small Cell Lung Carcinoma 1
Stage IIIA Non-Small Cell Lung Cancer 1
Stage IIIB Non-Small Cell Lung Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for technetium tc-99m albumin aggregated kit
Intervention Trials
Carcinoma, Non-Small-Cell Lung 1
Lung Neoplasms 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for technetium tc-99m albumin aggregated kit

Trials by Country

Trials by Country for technetium tc-99m albumin aggregated kit
Location Trials
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for technetium tc-99m albumin aggregated kit
Location Trials
Washington 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for technetium tc-99m albumin aggregated kit

Clinical Trial Phase

Clinical Trial Phase for technetium tc-99m albumin aggregated kit
Clinical Trial Phase Trials
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for technetium tc-99m albumin aggregated kit
Clinical Trial Phase Trials
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for technetium tc-99m albumin aggregated kit

Sponsor Name

Sponsor Name for technetium tc-99m albumin aggregated kit
Sponsor Trials
National Cancer Institute (NCI) 1
University of Washington 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for technetium tc-99m albumin aggregated kit
Sponsor Trials
NIH 1
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.